I think you're right to expect some info released by the company to update progress. I think frustration can sometimes sound like negativity but they are not the same. In any relationship that lasts, there must be interest shown one to another. There are many reasons why one person wanes in showing interest to another. It can be stress at work. It can be many things. But when one person asks, what's wrong and the other person is silent, speculation comes in. Is there someone else you're getting interested in? That is where, I believe, we are at with our investment. Last summer/fall there were reported trials going on with 10 fleets. So far, the only result that we know of is a deal with USA Metals. What happened? What's wrong? I have speculated that the large fleets are waiting for the newest generation of Hy Impact with telematics. The next generation adjusts the hydrogen injection as the rpm goes up and down for the best fuel economy. Paul Q111 has shared that this is not finished yet. So, I am not expecting to see much before the mid to end of 2nd quarter. That is just me-speculating on the little I know. Someone else may come to different conclusions and I respect that. I would love to be wrong and a blockbuster PR come out this afternoon, but I am not expecting that. I am expecting problems to be solved. I think that we have had little info from the company because there is little, at present, to say. It is very positive, to me, for the company to open HQ to shareholders to come and see what we are doing. To meet with other shareholders, some large, and to be able to meet with Mr. Coats. I also see it as a positive thing moving to a larger facility from two smaller ones. It hasn't come together as fast as any of us would've liked, but what I do see encourages me. My best to all, Jim
I think you're right to expect some info released by the
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
BIC's Latest Voting Rights and Shares Disclosure Details
Key Disclosure on Voting Rights and Shares As a reputable leader in stationery and consumer products, BIC is committed to transparency. Recently, they provided crucial insights into their corporate structure, particularly regarding the total number of voting rights and shares. This disclosure highlights the ongoing dedication towards maintaining clear communication with...
Continue Reading
AGCO Showcase: Innovations and Autonomy for 2026 Farmers
AGCO (NYSE: AGCO) is strutting its stuff at the 2026 Commodity Classic in San Antonio from February 25-27. Picture this: over 24,000 square feet jam-packed with cutting-edge agricultural machinery aimed at farmers who want to boost their operations. Yeah, the buzz is all about showcasing their big guns like Fendt®, Massey Ferguson®, and PTx™—but dig deeper into...
Continue Reading
Revolutionizing Healthcare Marketing with Ignite Pulse Solutions
Revolutionizing Healthcare Marketing with Ignite Pulse Solutions In the shifting landscape of healthcare marketing, WebMD Ignite introduces a significant enhancement aimed at assisting health systems in thriving amidst the challenges posed by AI and budget constraints. Presenting Ignite Pulse™, this groundbreaking solution offers a comprehensive growth strategy designed...
Continue Reading
Eupraxia Pharmaceuticals Welcomes New Leaders to Innovate Growth
Eupraxia Pharmaceuticals Expands Leadership Team Eupraxia Pharmaceuticals Inc. (TSX: EPRX) (NASDAQ: EPRX), known for its innovative approaches in drug delivery technology, has recently announced two significant additions to its leadership. Dr. Amanda Malone has been appointed as the Chief Operating and Scientific Officer, alongside Dr. Rahul Sarugaser as Executive Vice...
Continue Reading
Illumina Enhances Oncology Solutions for Better Cancer Care
Illumina's Latest Developments in Oncology In an exciting development, Illumina Inc. (NASDAQ: ILMN) has announced a significant expansion in its clinical oncology portfolio. This move aims to set a new standard of care and enhance access to precision therapies through advanced genomic profiling. Following the recent FDA approval of Illumina's TSO Comprehensive test, the...
Continue Reading